NCT05948085
- Conditions
- Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
- Locations
-
- Pfizer Clinical Research Unit - New Haven New Haven, Connecticut, United States
Clinical trial condition
Headache Disorders
Explore clinical trials studying Headache Disorders. Study availability and eligibility vary by location and protocol.
1,484 public trials
178 recruiting studies
Headache Disorders trial results
NCT04163185
- Conditions
- Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
- Locations
-
- Clinical Research Site Birmingham, Alabama, United States
- Clinical Research Site Birmingham, Alabama, United States
- Clinical Research Site Mobile, Alabama, United States
- Clinical Research Site Colton, California, United States
NCT06680206
- Conditions
- Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
- Locations
-
- Pfizer New York, United States
NCT05903040
- Conditions
- Brain Diseases, Central Nervous System Diseases, Chronic Migraine, +15 more
- Locations
-
- SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi Florence, Italy
- IRCCS National Neurological Institute "C. Mondino" Foundation Pavia, Italy
NCT03832998
- Conditions
- Brain Diseases, Central Nervous System Diseases, Headache, +9 more
- Locations
-
- Paradigm Clinical Research Center Inc San Diego, California, United States
- Childrens Hospital Colorado Aurora, Colorado, United States
- Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
- New England Institute for Clinical Research Stamford, Connecticut, United States
NCT04921384
- Conditions
- Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
- Locations
-
- The First Medical Center of The Chinese PLA General Hospital (301 Hospital) Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Guangzhou Medical University - Yanjiang Campus Guangzhou, Guangdong, China
- People's Hospital of Zhengzhou Zhengzhou, Henan, China
- Renmin Hospital of Wuhan University - Main Campus Wuhan, Hubei, China
Completed
A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
NCT05810038
- Conditions
- Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
- Locations
-
- The Second People's hospital of Hefei Hefei, Anhui, China
- Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
- The fourth people's hospital of chongqing Chongqing, Chongqing Municipality, China
NCT05064371
- Conditions
- Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
- Locations
-
- DOI Clinic Internal Medicine Hiroshima-Shi Naka-Ku, Hiroshima, Japan
- Jinnouchi Neurosurgery Clinic Kasuga-Shi, Hukuoka, Japan
- Ikeda Neurosurgical Clinic Kasuga-Shi, Hukuoka, Japan
- Mito Kyodo General Hospital Mito, Ibaraki, Japan
NCT05264714
- Conditions
- Brain Diseases, Central Nervous System Diseases, Cluster Headache, +4 more
- Locations
-
- Mayo Clinic Rochester Rochester, Minnesota, United States
NCT07329127
- Conditions
- Brain Diseases, Central Nervous System Diseases, Headache Disorders, +6 more
- Locations
-
- Aeginition Hospital of Athens Athens, Greece